Jefferies Financial Group Inc. Johnson & Johnson Call Options Transaction History

Jefferies Financial Group Inc.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $2.67 Million - $2.92 Million	18,500 Added 142.31%	31,500 $4.6 Million
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $1.06 Million - $1.11 Million	6,800 Added 109.68%	13,000 $2.06 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $1.75 Million - $1.91 Million	-12,000 Reduced 65.93%	6,200 $971,000
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $16 Million - $18 Million	-103,000 Reduced 84.98%	18,200 $2.83 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $17 Million - $18.3 Million	110,100 Added 991.89%	121,200 $20.1 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $15.7 Million - $18.7 Million	-103,900 Reduced 90.35%	11,100 $1.72 Million
Q4 2022 Sep 21, 2023	SELL	$160.2 - $179.79 $993,239 - $1.11 Million	-6,200 Reduced 5.12%	115,000 $20.3 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $18.4 Million - $20.7 Million	115,000 New	115,000 $20.3 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.